Major product and customer milestones signal
progress toward the future of CRM for life sciences
PLEASANTON, Calif., Aug. 28,
2023 /PRNewswire/ -- Veeva Systems (NYSE: VEEV)
today announced two major milestones as it advances Vault CRM – the
next generation of CRM for the life sciences industry. Vault CRM
had its first customer win with an innovative oncology biotech. The
early adopter plans to go live starting with their field medical
team in Q4 2023. Veeva also announced plans for the general release
of Vault CRM in April 2024.
"The Veeva product team has made remarkable progress since we
announced Vault CRM less than a year ago," said Tom Schwenger, Veeva president and COO. "By
focusing on product excellence, innovation, and customer success,
Vault CRM will have its first customer live in Q4 2023, an
important milestone as we look ahead to the future of CRM for the
industry."
Built on the Veeva Vault Platform for the unique needs of life
sciences, Vault CRM will include all the functionality of
market-leading Veeva CRM and new omnichannel capabilities. Vault
CRM Service Center – included with Vault CRM at no additional
charge – provides new call center capabilities inside sales and
hybrid reps can use to support the service-centric engagement
necessary for today's more complex therapies.
Vault CRM is planned for general availability in April 2024 and will then be sold as the
go-forward product for all new customers. The current Veeva CRM
solution built on the Salesforce platform will enter stability mode
after its final functional release in December 2023 to minimize change and provide a
smooth migration path to Vault CRM for existing Veeva CRM
customers. During stability mode, Veeva CRM releases will include
fixes for significant defects, compliance, platform compatibility,
and security updates. Veeva CRM will be supported until
September 2030.
Additional Information
For more on Vault CRM, visit:
veeva.com/VaultCRM
Connect with Veeva on LinkedIn:
linkedin.com/company/veeva-systems
About Veeva Systems
Veeva is the global leader in
cloud software for the life sciences industry. Committed to
innovation, product excellence, and customer success, Veeva serves
more than 1,000 customers, ranging from the world's largest
biopharmaceutical companies to emerging biotechs. As a Public
Benefit Corporation, Veeva is committed to balancing the interests
of all stakeholders, including customers, employees, shareholders,
and the industries it serves. For more information,
visit veeva.com.
Veeva Forward-looking Statements
This release contains forward-looking statements regarding Veeva's
products and services and the expected results or benefits from use
of our products and services, including certain of our new
solutions and applications that are still under development or not
generally available. These statements are based on our current
expectations. Actual results, availability, and any future events
relating to these products and services could differ materially
from those anticipated or provided in this release and we have
no obligation to update such statements. There are numerous risks
that have the potential to negatively impact our results, including
the risks and uncertainties disclosed in our filing on Form 10-Q
for the period ended April 30, 2023,
which you can find here (a summary of risks which may impact
our business can be found on pages 37 and 38), and in our
subsequent SEC filings, which you can access at sec.gov.
Contact:
Alison Borris
Veeva Systems
925-226-8821
alison.borris@veeva.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/veeva-announces-first-customer-win-and-april-2024-availability-for-vault-crm--the-next-generation-of-crm-for-life-sciences-301910485.html
SOURCE Veeva Systems